Articles Tagged With:
-
New Analysis of COGENT Data Supports Proton Pump Inhibitor Benefit
It shows comparable risks of gastrointestinal and cardiovascular events between low- and high-dose aspirin.
-
Acetazolamide in Mechanically Ventilated Patients with COPD: Is There a Benefit?
Compared to placebo, the use of acetazolamide in mechanically ventilated patients with COPD does not significantly reduce the duration of mechanical ventilation.
-
Communication Facilitators Potentially Can Improve Care for the Sickest ICU Patients
Highly trained communication facilitators who counseled families and met with physicians and nurses were shown to decrease symptoms of depression in family members at six months and decreased ICU length of stay without affecting mortality.
-
Delaying Intubation in Severe Alcohol Withdrawal
Delaying intubation until aspiration or cardiopulmonary decompensation did not affect mortality but increased the incidence of pneumonia and length of stay.
-
Patients Rarely Sleep in the ICU
Understanding the mechanisms of sleep deprivation in the ICU may help clinicians modify some of these factors to promote better quality sleep.
-
IRB Continuing Education Series Turns Students into Teachers
Newark, DE-based Christiana Care Health System’s long-time educational program was set up to keep research nurses up to date, but over time it lost its luster.
-
Smart Training Can Prevent Problems with New Technology
Adopting new electronic submission technology across a research enterprise organization can prove to be challenging for IRBs, which have a long list of stakeholders to train and educate.
-
Some Spit, Polish, and Creativity Can Solve IRBs’ Education Efforts
IRB leaders at Christiana Care Health System in Newark, DE, revamped their research education sessions in response to dwindling attendance numbers.
-
Transparency About Participation Incentives Could Benefit IRBs, Researchers, and Patients
While the issue of incentives raises a host of ethical issues for discussion, the problem is the dearth of data on what study participants have been compensated for all manner of studies and clinical trials.
-
What You Don’t Know About NIH RAC Review Changes Could Hurt
IRBs might not have asked for it, but the National Institutes of Health and the FDA have handed them a new responsibility when it comes to oversight of clinical trials involving human gene transfer.